Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 05 - 05 symbols : Jnj save search
Coronavirus (COVID-19) Update: FDA Limits Use of Janssen COVID-19 Vaccine to Certain Individuals
Published: 2022-05-05 (Crawled : 21:00) - fda.gov
JNJ | News | $148.53 -0.69% 0.18% 7.5M
|
Health Technology
|
| O: -2.32%
H: 0.0%
C: 0.0%
covid-19 fda vaccine covid
Business and Public Health Leaders Call for Stronger Action on Workplace Mental Health
Published: 2022-05-05 (Crawled : 18:00) - prnewswire.com
JNJ | News | $148.53 -0.69% 0.18% 7.5M
|
Health Technology
|
| O: 0.72%
H: 0.0%
C: 0.0%
health
The Severe Hypertriglyceridemia Market is Expected to Increase with a CAGR of 8.1% During the Study Period (2019-32) | DelveInsight
Published: 2022-05-05 (Crawled : 16:00) - prnewswire.com
JNJ | News | $148.53 -0.69% 0.18% 7.5M
|
Health Technology
|
| O: 0.72%
H: 0.0%
C: 0.0%
LLY | News | $732.2 -1.81% -0.84% 1.7M
|
Health Technology
|
| O: -0.36%
H: 0.0%
C: 0.0%
INCY | $51.74 0.17% 0.14% 1.6M
|
Health Technology
|
| O: 3.73%
H: 0.09%
C: -3.98%
ARWR | $23.29 -2.06% -2.13% 810K
|
Health Technology
|
| O: -0.98%
H: 0.23%
C: -5.52%
ETNB | $8.58 -3.81% -3.84% 870K
|
Health Technology
|
| O: -0.44%
H: 8.85%
C: 6.64%
expected market
Scopus BioPharma Announces Biotechnology Industry Leader Rejoins Board of Directors
Published: 2022-05-05 (Crawled : 13:20) - biospace.com/
SCPS | $0.1682
|
|
| O: 0.0%
H: 0.0%
C: -4.48%
JNJ | News | $148.53 -0.69% 0.18% 7.5M
|
Health Technology
|
| O: 0.72%
H: 0.0%
C: 0.0%
ZEAL | $17.59 1.21% -4.21%
|
Health Technology
|
| O: 0.0%
H: 1.8%
C: -6.13%
GLPG | News | $28.77 -2.31% -2.33% 130K
|
Health Technology
|
| O: -2.08%
H: 1.48%
C: -0.91%
biopharma
Arcturus Reports Strong Three-Month Durability Results from ARCT-154 Booster Trial
Published: 2022-05-05 (Crawled : 13:00) - biospace.com/
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: 0.55%
H: 0.0%
C: -1.16%
JNJ | News | $148.53 -0.69% 0.18% 7.5M
|
Health Technology
|
| O: 0.72%
H: 0.0%
C: 0.0%
ARCT 4 | $26.98 -3.4% -3.44% 270K
|
Health Technology
|
| O: 6.93%
H: 1.13%
C: -8.47%
arct-154 trial results
Hillstream BioPharma to Present at BioNJ's 12th Annual BioPartnering Virtual Conference Held on May 9- 13, 2022
Published: 2022-05-05 (Crawled : 13:00) - globenewswire.com
JNJ | News | $148.53 -0.69% 0.18% 7.5M
|
Health Technology
|
| O: 0.72%
H: 0.0%
C: 0.0%
biopharma conference
Bavarian Nordic Reports Omicron Data from Phase 2 Trial of its COVID-19 Booster Vaccine Candidate
Published: 2022-05-05 (Crawled : 09:00) - globenewswire.com
JNJ | News | $148.53 -0.69% 0.18% 7.5M
|
Health Technology
|
| O: 0.72%
H: 0.0%
C: 0.0%
covid-19 vaccine trial phase 2
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M
|
Consumer Services
BOF | $2.08 77.78% 41.21% 110M
|
ILAG | $0.54 12.27% 40.62% 3.7M
|
LICN | $0.999 78.39% 40.49% 15M
|
AMST | $3.4 70.0% 39.58% 70M
|
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.458 14.5% 30.92% 91K
|
Health Services
MULN | News | $3.77 38.1% 27.78% 13M
|
Information
RILY | $29.75 36.97% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.